Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Short Interest Down 66.1% in January

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSFGet Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 19,500 shares, a decrease of 66.1% from the December 31st total of 57,500 shares. Based on an average daily volume of 500 shares, the short-interest ratio is currently 39.0 days.

Shanghai Fosun Pharmaceutical (Group) Price Performance

Shares of SFOSF stock remained flat at $1.70 on Tuesday. The company’s 50 day moving average is $1.80 and its two-hundred day moving average is $1.74. Shanghai Fosun Pharmaceutical has a twelve month low of $1.50 and a twelve month high of $2.24.

About Shanghai Fosun Pharmaceutical (Group)

(Get Free Report)

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments.

Featured Articles

Receive News & Ratings for Shanghai Fosun Pharmaceutical (Group) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shanghai Fosun Pharmaceutical (Group) and related companies with MarketBeat.com's FREE daily email newsletter.